Purification of antibodies to O antigen of Salmonella Typhimurium from human serum by affinity chromatography

Journal of Immunological Methods

Volumn 387, Issue 1-2, 2013, Pages 199-210

  O'Shaughnessy, Colette M ^a,b   Micoli, Francesca ^a   Gavini, Massimiliano ^a   Goodall, Margaret ^b   Cobbold, Mark ^b   Saul, Allan ^a   MacLennan, Calman A ^a,b  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Affinity; Antibody; O antigen; Purification; Salmonella; Serum

Indexed keywords

BACTERIUM ANTIBODY; O ANTIBODY; O ANTIGEN; PERIODATE SODIUM; RESIN; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANTIBODY AFFINITY; ANTIGEN BINDING; ARTICLE; BACTERICIDAL ACTIVITY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PURIFICATION; SALMONELLA TYPHIMURIUM;

ADIPATES; ADULT; ANIMALS; ANTIBODIES, BACTERIAL; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; O ANTIGENS; RABBITS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SERUM;

ORYCTOLAGUS CUNICULUS; SALMONELLA; SALMONELLA TYPHIMURIUM;

EID: 84871406256     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.10.015     Document Type: Article

References (46)

1. Altman E., Bundle D.R. Polysaccharide affinity columns for purification of lipopolysaccharide-specific murine monoclonal antibodies. Methods Enzymol. 1994, 247:243.
2. Baines M.G., Thorpe R. Purification of immunoglobulin g (IgG). Methods Mol. Biol. 1992, 80:79.
3. Brent A.J., Oundo J.O., Mwangi I., Ochola L., Lowe B., Berkley J.A. Salmonella bacteremia in Kenyan children. Pediatr. Infect. Dis. J. 2006, 25:230.
4. Casey J.L., Keep P.A., Chester K.A., Robson L., Hawkins R.E., Begent R.H. Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography. J. Immunol. Methods 1995, 179:105.
5. Cuatrecasas P. Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads. J. Biol. Chem. 1970, 245:3059.
6. Cuatrecasas P., Anfinsen C.B. Methods in Enzymology 1971, 345. Academic Press.
7. DuBois M., Gilles K.A., Hamilton J.K., Rebers P.A., Smith F. Colorimetric method for determination of sugars and related substances. Anal. Chem. 1956, 28:350.
8. Fox J., Hechemy K. Coupling of Escherichia coli lipopolysaccharide to epoxy-activated Sepharose 6B. Infect. Immun. 1978, 20:867.
9. Gil-Cruz C., Bobat S., Marshall J.L., Kingsley R.A., Ross E.A., Henderson I.R., Leyton D.L., Coughlan R.E., Khan M., Jensen K.T., Buckley C.D., Dougan G., MacLennan I.C., Lopez-Macias C., Cunningham A.F. The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9803.
10. Girard R., Goichot J. Preparation of monospecific anti-Salmonella lipopolysaccharide antibodies by affinity chromatography. Ann. Immunol. 1981, 132C:211. (Paris).
11. Gondwe E.N., Molyneux M.E., Goodall M., Graham S.M., Mastroeni P., Drayson M.T., MacLennan C.A. Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3070.
12. Gordon M.A., Banda H.T., Gondwe M., Gordon S.B., Boeree M.J., Walsh A.L., Corkill J.E., Hart C.A., Gilks C.F., Molyneux M.E. Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 2002, 16:1633.
13. Gordon M.A., Graham S.M., Walsh A.L., Wilson L., Phiri A., Molyneux E., Zijlstra E.E., Heyderman R.S., Hart C.A., Molyneux M.E. Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin. Infect. Dis. 2008, 46:963.
14. Graham S.M., Molyneux E.M., Walsh A.L., Cheesbrough J.S., Molyneux M.E., Hart C.A. Nontyphoidal Salmonella infections of children in tropical Africa. Pediatr. Infect. Dis. J. 2000, 19:1189.
15. Hellerqvicst G., Lindberg B., Svenson S., Holme T., Lindberg A. Structural studies on the 0-specific side-chains of the cell wall lipopolysaccharide from Salmonella typhimurium LT2. Carbohydr. Res. 1969, 9:237.
16. Huse K., Bohme H.J., Scholz G.H. Purification of antibodies by affinity chromatography. J. Biochem. Biophys. Methods 2002, 51:217.
17. Jack G.W. Immunoaffinity chromatography. Mol. Biotechnol. 1994, 1:59.
18. Jorbeck H.J., Svenson S.B., Lindberg A.A. Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit opsonizing antibodies that enhance phagocytosis. Infect. Immun. 1981, 32:497.
19. Kingsley R.A., Msefula C.L., Thomson N.R., Kariuki S., Holt K.E., Gordon M.A., Harris D., Clarke L., Whitehead S., Sangal V., Marsh K., Achtman M., Molyneux M.E., Cormican M., Parkhill J., MacLennan C.A., Heyderman R.S., Dougan G. Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res. 2009, 19:2279.
20. Konadu E., Shiloach J., Bryla D.A., Robbins J.B., Szu S.C. Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls. Infect. Immun. 1996, 64:2709.
21. Macgee J., Doudoroff M. A new phosphorylated intermediate in glucose oxidation. J. Biol. Chem. 1954, 210:617.
22. MacLennan C.A., Gondwe E.N., Msefula C.L., Kingsley R.A., Thomson N.R., White S.A., Goodall M., Pickard D.J., Graham S.M., Dougan G., Hart C.A., Molyneux M.E., Drayson M.T. The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J. Clin. Invest. 2008, 118:1553.
23. MacLennan C.A., Gilchrist J.J., Gordon M.A., Cunningham A.F., Cobbold M., Goodall M., Kingsley R.A., van Oosterhout J.J., Msefula C.L., Mandala W.L., Leyton D.L., Marshall J.L., Gondwe E.N., Bobat S., Lopez-Macias C., Doffinger R., Henderson I.R., Zijlstra E.E., Dougan G., Drayson M.T., MacLennan I.C., Molyneux M.E. Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults. Science 2010, 328:508.
24. Micoli F., Rondini S., Pisoni I., Giannelli C., Di C.V., Costantino P., Saul A., Martin L.B. Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi. Vaccine 2012, 30:853.
25. Molyneux E.M., Mankhambo L.A., Phiri A., Graham S.M., Forsyth H., Phiri A., Walsh A.L., Wilson L.K., Molyneux M.E. The outcome of non-typhoidal Salmonella meningitis in Malawian children, 1997-2006. Ann. Trop. Paediatr. 2009, 29:13.
26. Morpeth S.C., Ramadhani H.O., Crump J.A. Invasive non-Typhi Salmonella disease in Africa. Clin. Infect. Dis. 2009, 49:606.
27. Mukkur T.K. Thermodynamics of hapten-antibody interactions. CRC Crit. Rev. Biochem. 1984, 16:133.
28. Narhi L.O., Caughey D.J., Horan T., Kita Y., Chang D., Arakawa T. Effect of three elution buffers on the recovery and structure of monoclonal antibodies. Anal. Biochem. 1997, 253:236.
29. Narhi L.O., Caughey D.J., Horan T.P., Kita Y., Chang D., Arakawa T. Fractionation and characterization of polyclonal antibodies using three progressively more chaotropic solvents. Anal. Biochem. 1997, 253:246.
30. Page M., Thorpe R. The Protein Protocols Handbook 2002, 985. Humana Pr Inc.
31. Palmer D.W., Peters T. Automated determination of free amino groups in serum and plasma using 2,4,6-trinitrobenzene sulfonate. Clin. Chem. 1969, 15:891.
32. Reddy E.A., Shaw A.V., Crump J.A. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect. Dis. 2010, 10:417.
33. Rodahl E., Maeland J.A. Affinity chromatography for purification of antibodies to Neisseria gonorrhoeae and Neisseria meningitidis lipopolysaccharides. Acta Pathol. Microbiol. Immunol. Scand. C 1984, 92:247.
34. Rondini S., Micoli F., Lanzilao L., Hale C., Saul A.J., Martin L.B. Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi. Clin. Vaccine Immunol. 2011, 18:460.
35. Sakurabayashi I. Dynamics of antigen-antibody interaction - an introduction. Nihon Rinsho 1995, 53:2126.
36. Satake K., Okuyama T., Ohasi M., Shinoda T. The spectrophotometric determination of amine, amino acid and peptide with 2,4,6-trinitrobenzene 1-sulfonic acid. J. Biochem. 1960, 47:654.
37. Simon R., Tennant S.M., Wang J.Y., Schmidlein P.J., Lees A., Ernst R.K., Pasetti M.F., Galen J.E., Levine M.M. Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis. Infect. Immun. 2011, 79:4240.
38. Singh S.P., Williams Y.U., Benjamin W.H., Klebba P.E., Boyd D. Immunoprotection by monoclonal antibodies to the porins and lipopolysaccharide of Salmonella typhimurium. Microb. Pathog. 1996, 21:249.
39. Smith-Gill S.J. Molecular recognition of lysozyme by monoclonal antibodies. EXS 1996, 75:277.
40. Smith-Gill S.J., Wilson A.C., Potter M., Prager E.M., Feldmann R.J., Mainhart C.R. Mapping the antigenic epitope for a monoclonal antibody against lysozyme. J. Immunol. 1982, 128:314.
41. Stiller J.M., Nielsen K.H. Affinity purification of bovine antibodies to Brucella abortus lipopolysaccharide. J. Clin. Microbiol. 1983, 17:323.
42. Svenson S.B., Lindberg A.A. Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice. Infect. Immun. 1981, 32:490.
43. Watson D.C., Robbins J.B., Szu S.C. Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine. Infect. Immun. 1992, 60:4679.
44. Whitfield C., Kaniuk N., Frirdich E. Molecular insights into the assembly and diversity of the outer core oligosaccharide in lipopolysaccharides from Escherichia coli and Salmonella. J. Endotoxin Res. 2003, 9:244.
45. Wollin R., Stocker B.A., Lindberg A.A. Lysogenic conversion of Salmonella typhimurium bacteriophages A3 and A4 consists of O-acetylation of rhamnose of the repeating unit of the O-antigenic polysaccharide chain. J. Bacteriol. 1987, 169:1003.
46. Yarmush M.L., Weiss A.M., Antonsen K.P., Odde D.J., Yarmush D.M. Immunoaffinity purification: basic principles and operational considerations. Biotechnol. Adv. 1992, 10:413.